Home > Category > Signaling Pathways > Metabolism > Factor VIII > Anti-Human F9xF10 Bispecific Antibody(Emicizumab;RO 5534262, ACE 910;RG6013,hBS910;coagulation factor 10, coagulation factor X;coagulation factor 9, coagulation factor IX)

Anti-Human F9xF10 Bispecific Antibody(Emicizumab;RO 5534262, ACE 910;RG6013,hBS910;coagulation factor 10, coagulation factor X;coagulation factor 9, coagulation factor IX)

ChemLeader 95+%
Catalog No:CLA1401 CAS No.:1610943-06-0 MDLNo: Formula: MW:
Size Availability Price(USD) VIP Price (USD) Quantity

There is no price information at the moment, you can send an inquiry,and we will reply to you as soon as possible.

Chemical safety data sheet(MSDS)

Download MSDS
  • Product Overview
  • Related documents
  • Product details
  • Related literature
Product Overview
Product Name Anti-Human F9xF10 Bispecific Antibody(Emicizumab;RO 5534262, ACE 910;RG6013,hBS910;coagulation factor 10, coagulation factor X;coagulation factor 9, coagulation factor IX)
CAS1610943-06-0
Storage conditionstore at -20°C
Product details

Emicizumab is a   bispecific monoclonal antibody that simulates the function of coagulation Factor VIII by bridging activated Factor IX and Factor X. It's approved for routine prophylaxis to prevent or reduce bleeding episodes in adults and children with hemophilia A, with or without Factor VIII inhibitors.

Related literature
Related
Sorry, no related items
Service
ChemLeader
021-58180488
Online service time: 9:00-18:00 on weekdays